Pressor Polypeptides Formed in Vivo and in Vitro as Mediators of Renal Hypertension
- 1 April 1958
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 17 (4) , 668-671
- https://doi.org/10.1161/01.cir.17.4.668
Abstract
During the purification of hypertensin formed in vitro, evidence of heterogeneity of the pressor activity was obtained by counter current distribution. Pepsitensin shows a similar heterogeneity. These facts lead to the hypothesis that other proteolytic enzymes may also be present in the tissues and may hydrolyze hypertensinogen with the formation of pressor polypeptides of the hypertensin or pepsitensin type. Thus, substances similar to hypertensin may be formed in the organism by the action of proteolytic enzymes other than renin and may, if produced locally, exert a vasoconstrictor action or, if they enter the circulation, cause an increase in blood pressure.Keywords
This publication has 10 references indexed in Scilit:
- SOME ASPECTS OF INFLAMMATION AND INFECTIONThe Lancet, 1957
- Synthese von Hypertensin‐II‐peptidenAngewandte Chemie, 1957
- Pressor and Myotrophic Activities of Incubated Plasma.Experimental Biology and Medicine, 1957
- The amino acid sequence in a hypertensinBiochemical Journal, 1957
- Pharmacologically Active Lipid-Soluble Acids of Natural OccurrenceNature, 1957
- THE AMINO ACID SEQUENCE OF HYPERTENSIN IIThe Journal of Experimental Medicine, 1956
- The isolation of a hypertensinBiochemical Journal, 1956
- Untersuchungen über die vasoconstrictorische Aktivität im Plasma essentieller HypertonikerJournal of Molecular Medicine, 1956
- Heterogeneity of hypertensin preparationsBiochimica et Biophysica Acta, 1955
- ENZYMATIC CLEAVAGE OF GLYCINAMIDE FROM VASOPRESSIN AND A PROPOSED STRUCTURE FOR THIS PRESSOR-ANTIDIURETIC HORMONE OF THE POSTERIOR PITUITARYJournal of the American Chemical Society, 1953